Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

During phase 2, subjects were recruited directly by the study investigators. The Salmeterol Multicenter Asthma Research Trial (SMART) was a multicenter, randomized, double-blind, parallel-group ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

After hours: January 31 at 7:58:37 p.m. EST ...